Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Comparison of three commercial batches of the Japanese encephalitis vaccine IC51. Double blind, randomized, controlled phase 3 study

Next Previous
X
Search
Trial Profile

Comparison of three commercial batches of the Japanese encephalitis vaccine IC51. Double blind, randomized, controlled phase 3 study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2013

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs IC 51 (Primary)
  • Indications Encephalitis virus infections
  • Focus Pharmacodynamics
  • Sponsors Intercell

    • Most Recent Events

    • 22 Jun 2008 Actual completion date is changed from Feb 2008 to June 2008 as reported by ClinicalTrials.gov.
    • 10 Mar 2008 Status changed from in progress to completed.
    • 01 Feb 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top